Veradermics/$MANE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Veradermics

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Ticker

$MANE
Sector
Health

Primary listing

NYSE

Employees

-
Headquarters
New Haven, United States
Website
www.veradermics.com

Veradermics Metrics

BasicAdvanced
$4.6bn
-
-$15.84
-
-

What the Analysts think about Veradermics

Analyst ratings (Buy, Hold, Sell) for Veradermics stock.

Veradermics Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Veradermics Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Veradermics News

AllArticlesVideos
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Business Wire9 hours ago
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302' in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy

Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302' in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy

Business Wire4 weeks ago
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months

Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months

Benzinga4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.